RENALYTIX PLC - AMERICAN DEPOSITARY SHARES

Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors

03 يوليو 2023 07:00:00 بحسب Nasdaq GlobeNewswire

FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease

29 يونيو 2023 18:01:17 بحسب Nasdaq GlobeNewswire

KidneyIntelX™ Clinical Decision Impact / Validation and Health Economic Data to be Presented at Upcoming Scientific Conferences

15 يونيو 2023 07:00:01 بحسب Nasdaq GlobeNewswire

Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023

09 يونيو 2023 07:00:54 بحسب Nasdaq GlobeNewswire

Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9

05 يونيو 2023 07:00:10 بحسب Nasdaq GlobeNewswire

Renalytix selects EVERSANA® to expand commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes

25 مايو 2023 07:00:00 بحسب Nasdaq GlobeNewswire

New Published Real-World Evidence Shows KidneyIntelX™ Utility

19 أبريل 2023 07:00:28 بحسب Nasdaq GlobeNewswire

Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting

12 أبريل 2023 07:00:26 بحسب Nasdaq GlobeNewswire

Renalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial Results

30 مارس 2023 07:00:16 بحسب Nasdaq GlobeNewswire

Renalytix to Report Second Quarter and First Half Fiscal Year 2023 Financial Results on March 30

22 مارس 2023 07:00:27 بحسب Nasdaq GlobeNewswire

Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

09 فبراير 2023 07:00:12 بحسب Nasdaq GlobeNewswire

Renalytix announces a c.$20.3 million private placement

08 فبراير 2023 07:00:49 بحسب Nasdaq GlobeNewswire

Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United States

26 يناير 2023 07:00:01 بحسب Nasdaq GlobeNewswire

Renalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systems

09 يناير 2023 07:00:02 بحسب Nasdaq GlobeNewswire

Primary Care Use of KidneyIntelX in Early Stage CKD Improved Clinical Care Delivery and Outcomes

01 ديسمبر 2022 07:00:00 بحسب Nasdaq GlobeNewswire

Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023

30 نوفمبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire

Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease

29 نوفمبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire

Renalytix to Report Financial Results for First Quarter Fiscal Year 2023 on November 30

22 نوفمبر 2022 07:00:00 بحسب Nasdaq GlobeNewswire

Renalytix to Present at Stifel Healthcare Conference

03 نوفمبر 2022 07:00:02 بحسب Nasdaq GlobeNewswire

Renalytix Reports Full Year Fiscal 2022 Results

31 أكتوبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire